The elevated plasma FABP4 level is a negative prognostic factor, correlated with metabolic syndrome, insulin resistance (calculated as HOMA-IR), and mortality of patients with advanced hepatic cirrhosis and sepsis [31, 33]. This evidence concerns the gene FABP4 and metabolic syndrome.